UPDATE 2-Abbott results bode well for spun-off AbbVie
By:
CNBC.com News
*Humira sales growth a good sign for AbbVie. *Abbott shares slip; AbbVie shares rise nearly 2 percent. Jan 23- AbbVie Inc, the new branded pharmaceuticals company spun off by Abbott Laboratories Inc, is off to a good start, judging by fourth-quarter sales of arthritis drug Humira and other products in its medicine chest.
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here